Mineralocorticoids participate in the reduced vascular reactivity of pregnant rats

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 302, Issue 5, 2012, Pages

  Provencher, M ^a,b   Houde, V ^a   Brochu, M ^a   St Louis, J ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

ATP sensitive potassium channels; Highconductance calcium activated potassium channels; Potassium canrenoate; Renin angiotensin aldosterone system; Voltage dependent calcium channels

Indexed keywords

1 (2 HYDROXY 5 TRIFLUOROMETHYLPHENYL) 5 TRIFLUOROMETHYL 2(3H) BENZIMIDAZOLONE; CALCIUM CHANNEL; CANRENOIC ACID; CROMAKALIM; MINERALOCORTICOID RECEPTOR; NIFEDIPINE; PHENYLEPHRINE; POTASSIUM CHANNEL; POTASSIUM CHLORIDE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ALDOSTERONE; ALDOSTERONE ANTAGONIST; BENZIMIDAZOLE DERIVATIVE; CALCIUM ACTIVATED POTASSIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CANRENOATE POTASSIUM; MINERALOCORTICOID; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENUATION; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; NONHUMAN; PREGNANCY OUTCOME; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM; VASCULAR RING; VASOCONSTRICTION; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; PHYSIOLOGY; PREGNANCY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPRAGUE DAWLEY RAT; THORACIC AORTA; VASCULAR SMOOTH MUSCLE;

ALDOSTERONE; ALDOSTERONE ANTAGONISTS; ANIMALS; AORTA, THORACIC; BENZIMIDAZOLES; CALCIUM CHANNEL BLOCKERS; CANRENOATE POTASSIUM; CROMAKALIM; FEMALE; KATP CHANNELS; MINERALOCORTICOIDS; MUSCLE, SMOOTH, VASCULAR; NIFEDIPINE; PHENYLEPHRINE; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; POTASSIUM CHLORIDE; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, MINERALOCORTICOID; RENIN-ANGIOTENSIN SYSTEM; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 84857323532     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00510.2011     Document Type: Article

References (44)

1. Ambroisine ML, Favre J, Oliviero P, Rodriguez C, Gao J, Thuillez C, Samuel JL, Richard V, Delcayre C. Aldosterone-induced coronary dysfunction in transgenic mice involves the calcium-activated potassium (BKCa) channels of vascular smooth muscle cells. Circulation 116: 2435-2443, 2007.
2. Atherton JC, Dark JM, Garland HO, Morgan MR, Pidgeon J, Soni S. Changes in water and electrolyte balance, plasma volume and composition during pregnancy in the rat. J Physiol 330: 81-93, 1982.
3. + and Ca2+ function. Am J Physiol Heart Circ Physiol 287: H1848-H1856, 2004.
4. Beausejour A, Auger K, St-Louis J, Brochu M. High-sodium intake prevents pregnancy-induced decrease of blood pressure in the rat. Am J Physiol Heart Circ Physiol 285: H375-H383, 2003.
5. Booth RE, Johnson JP, Stockand JD. Aldosterone. Adv Physiol Educ 26: 8-20, 2002.
6. Brayden JE. Functional roles of KATP channels in vascular smooth muscle. Clin Exp Pharmacol Physiol 29: 312-316, 2002.
7. Brochu M, Lehoux JG, Picard S. Effects of gestation on enzymes controlling aldosterone synthesis in the rat adrenal. Endocrinology 138: 2354-2358, 1997.
8. Cachofeiro V, Miana M, de Las HN, Martin-Fernandez B, Ballesteros S, Fernandez-Tresguerres J, Lahera V. Aldosterone and the vascular system. J Steroid Biochem Mol Biol 109: 331-335, 2008.
9. Cadorette C, Sicotte B, Brochu M, St-Louis J. Effects of potassium channel modulators on myotropic responses of aortic rings of pregnant rats. Am J Physiol Heart Circ Physiol 278: H567-H576, 2000.
10. Chapman AB, Abraham WT, Zamudio S, Coffin C, Merouani A, Young D, Johnson A, Osorio F, Goldberg C, Moore LG, Dahms T, Schrier RW. Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. Kidney Int 54: 2056-2063, 1998.
11. Crews JK, Novak J, Granger JP, Khalil RA. Stimulated mechanisms of Ca2+ entry into vascular smooth muscle during NO synthesis inhibition in pregnant rats. Am J Physiol Regul Integr Comp Physiol 276: R530-R538, 1999.
12. De WH, Allen M, Holmes C, Stobbart M, Lippiat JD, Callaghan R. Modulation of the BK channel by estrogens: examination at single channel level. Mol Membr Biol 23: 420-429, 2006.
13. Duprez DA. Aldosterone and the vasculature: mechanisms mediating resistant hypertension. J Clin Hypertens (Greenwich) 9: 13-18, 2007.
14. Ezimokhai M, Osman N. Calcium supplementation is associated with endothelium dependent attenuation of vascular smooth muscle reactivity in normotensive pregnant and nonpregnant rats. Am J Hypertens 11: 88-96, 1998.
15. + channels containing Kir6.1 and Kir62 subunits. Cardiovasc Res 79: 621-631, 2008.
16. Flagg TP, Enkvetchakul D, Koster JC, Nichols CG. Muscle KATP channels: recent insights to energy sensing and myoprotection. Physiol Rev 90: 799-829, 2010.
17. Funder JW. Minireview: aldosterone and the cardiovascular system: genomic and nongenomic effects. Endocrinology 147: 5564-5567, 2006.
18. Garland HO, Atherton JC, Baylis C, Morgan MR, Milne CM. Hormone profiles for progesterone, oestradiol, prolactin, plasma renin activity, aldosterone and corticosterone during pregnancy and pseudopregnancy in two strains of rat: correlation with renal studies. J Endocrinol 113: 435-444, 1987.
19. Hadden DR, McLaughlin C. Normal and abnormal maternal metabolism during pregnancy. Semin Fetal Neonatal Med 14: 66-71, 2009.
20. Heylen E, Huang A, Sun D, Kaley G. Nitric oxide-mediated dilation of arterioles to intraluminal administration of aldosterone. J Cardiovasc Pharmacol 54: 535-542, 2009.
21. + channels (BKCa) and arteriolar myogenic signaling. FEBS Lett 584: 2033-2042, 2010.
22. +ATP channel inhibition on total and regional vascular resistance in guinea pig pregnancy. Am J Physiol Heart Circ Physiol 275: H680-H688, 1998.
23. McCurley A, Jaffe IZ. Mineralocorticoid receptors in vascular function and disease. Mol Cell Endocrinol 2011 doi: 10.1016/j.mce.2011.06.014.
24. Meyer MC, Brayden JE, McLaughlin MK. Characteristics of vascular smooth muscle in the maternal resistance circulation during pregnancy in the rat. Am J Obstet Gynecol 169: 1510-1516, 1993.
25. Mironneau J. Calcium channel antagonist effects of spironolactone, an aldosterone antagonist. Am J Cardiol 65: 7K-8K, 1990.
26. Moutquin JM, Rainville C, Giroux L, Raynauld P, Amyot G, Bilodeau R, Pelland N. A prospective study of blood pressure in pregnancy: prediction of preeclampsia. Am J Obstet Gynecol 151: 191-196, 1985.
27. Nelson MT, Cheng H, Rubart M, Santana LF, Bonev AD, Knot HJ, Lederer WJ. Relaxation of arterial smooth muscle by calcium sparks. Science 270: 633-637, 1995.
28. Nelson MT, Patlak JB, Worley JF, Standen NB. Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle tone. Am J Physiol Cell Physiol 259: C3-C18, 1990.
29. Nelson MT, Quayle JM. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol Cell Physiol 268: C799-C822, 1995.
30. Poston L. Maternal vascular function in pregnancy. J Hum Hypertens 10: 391-394, 1996.
31. + channel and cGMP-dependent signaling pathway in uterine vascular smooth muscle. Am J Physiol Heart Circ Physiol 296: H1878-H1887, 2009.
32. + channels regulate basal uteroplacental blood flow in ovine pregnancy. J Soc Gynecol Investig 12: 402-408, 2005.
33. Roy B, Sicotte B, Brochu M, St-Louis J. Effects of nifedipine and Bay K 8644 on myotropic responses in aortic rings of pregnant rats. Eur J Pharmacol 280: 1-9, 1995.
34. Roy B, Sicotte B, Brochu M, St-Louis J. Modulation of calcium mobilization in aortic rings of pregnant rats: Contribution of extracellular calcium and of voltage-operated calcium channels. Biol Reprod 60: 979-988, 1999.
35. Roy-Clavel E, Picard S, St-Louis J, Brochu M. Induction of intrauterine growth restriction with a low-sodium diet fed to pregnant rats. Am J Obstet Gynecol 180: 608-613, 1999.
36. St-Louis J, Brochu M. The cardiovascular paradox of pregnancy. Med Sci (Paris) 23: 944-949, 2007.
37. St-Louis J, Massicotte G, Parent A. Effet anti-hypertenseur de la grossesse: influence de la réactivité vasculaire. Méd Sci 6: 358-365, 1988.
38. St-Louis J, Pare H, Roy B, Brochu M. Decreased response to vasopressin in the mesenteric resistance arteries of pregnant rats: effects of nifedipine and Bay K 8644. J Soc Gynecol Investig 2: 516-522, 1995.
39. Torgersen KL, Curran CA. A systematic approach to the physiologic adaptations of pregnancy. Crit Care Nurs Q 29: 2-19, 2006.
40. + and Ca2+ channel gene expression by chronic treatment with estrogen and tamoxifen in rat aorta. Eur J Pharmacol 483: 155-162, 2004.
41. Valverde MA, Rojas P, Amigo J, Cosmelli D, Orio P, Bahamonde MI, Mann GE, Vergara C, Latorre R. Acute activation of Maxi-K channels (hSlo) by estradiol binding to the beta subunit. Science 285: 1929-1931, 1999.
42. Viengchareun S, Le MD, Martinerie L, Munier M, Pascual-Le TL, Lombes M. The mineralocorticoid receptor: insights into its molecular and (patho)physiological biology. Nucl Recept Signal 5: e012, 2007.
43. Wehling M. Effects of aldosterone and mineralocorticoid receptor blockade on intracellular electrolytes. Heart Fail Rev 10: 39-46, 2005.
44. Yu X, Ma H, Barman SA, Sellers M, Stallone JN, Prossnitz ER, White RE, Han G. Activation of G protein-coupled estrogen receptor (GPER) induces endothelium- independent relaxation of coronary artery smooth muscle. Am J Physiol Endocrinol Metab 301: E882-E888, 2011.